SOTAC PHARMACEUTICALS
Back to Cashflow Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹30 Cr | ₹13 Cr | ₹-2.83 Cr | ₹3.38 Cr | ₹11 Cr |
What is the latest Cash Flow from Financing Activities ratio of SOTAC PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹30 Cr |
Mar2023 | ₹13 Cr |
Mar2022 | ₹-2.83 Cr |
Mar2021 | ₹3.38 Cr |
Mar2020 | ₹11 Cr |
How is Cash Flow from Financing Activities of SOTAC PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹30 Cr | 124.86 | |
Mar2023 | ₹13 Cr | Positive | |
Mar2022 | ₹-2.83 Cr | Negative | |
Mar2021 | ₹3.38 Cr | -70.36 | |
Mar2020 | ₹11 Cr | - |
Compare Cash Flow from Financing Activities of peers of SOTAC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SOTAC PHARMACEUTICALS | ₹119.9 Cr | -2.7% | -13.9% | -19.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
SOTAC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOTAC PHARMACEUTICALS | -2.7% |
-13.9% |
-19.6% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses